Press Releases from SMi Group (942 total)
Receive European Pharmaceutical Pricing & Reimbursement updates from EMIG, EUCOP …
The UK's Department of Health has said there will be no further price cuts for branded medicines not funded via the voluntary Pharmaceutical Price Regulation…
Industry Survey: Pre-Filled Syringes and Medical Devices
SMi Group announces the launch of Industry Wide Survey for Pre-Filled Syringes and Medical Devices and invites industry professionals to take part in it. The…
Develop the right strategy following the advancement of pre-filled syringe syste …
The boom in biotechnology was undoubtedly a fundamental driver for pre-filled syringes. It decreases the chances of dosage errors, improving sterility, assuring patient compliance and…
SMi announces the 16th annual Generics and Patent Strategies London
SMi is pleased to announce the 16th annual Generics and Patent Strategies conference taking place in London from 13-14 May 2013. The conference will see…
Lyophilisation 2013 – Freeze-Drying in Pharmaceuticals and Biopharmaceuticals
In pharmaceutical storage and transportation, freeze-drying has been proven an essential method for pharmaceutical companies to distribute and store their products effectively, efficiently and inexpensively.…
Evaluate social media as a valuable strategic resource | Social Media within the …
Social media is a phenomenon. Social networks have made it easy to keep up with friends, organise your life, publicly express thoughts, share interests, provide…
Review developments in combat casualty response | Battlefield Healthcare
Many key developments in healthcare have their origins in the battlefield where the treatment of injured troops has led to innovations throughout history which continue…
Last chance to register for UAS 2012
The UK’s leading UAS event will continue to explore the growth and development of the international Unmanned Aerial System market.
UAS 2012 will take place in…
SMi’s 5th Social Media in the Pharmaceutical Industry: Connectivity, Engagemen …
Over the last decade, social media has become integrated into every aspect of business in every industry. The pharmaceutical industry, however, has very traditional methods…
SMi’s 4th annual COPD: Novel therapeutics and Management Strategies conference
SMi’s 4th annual COPD: Novel Therapeutics & Management Strategies conference held on the 22nd & 23rd October in London will address therapeutic and management strategies…
Latest developments in techniques and procedures used in the identification and …
Microbiological contamination of products and processes in a lab and manufacturing environment continues to be a major problem to the Pharmaceutical and Biotechnological industries and…
SMi’s 6th annual Biomarkers Summit 2013 - Innovations in stratified medicine
The drive towards personalized medicine is seeing pharma move from patient stratification as a ‘nice to have’, to an essential feature of product development.…
SMi Group Ltd Confirm EDP Distribuição for Smart Grids this September
SMi Group Ltd are pleased to announce Headline Sponsor Vodafone have confirmed for the 2nd annual Telecoms for Smart Grids conference, and their Head of…
Current developments in Neurodegenerative Treatments
The central nervous system is a fundamental part of the human body's response system, creating a massive range of reactions, targets, and in turn, diseases.…
Partnership factors in sponsor – CRO relationships
Drugs discovered today can realistically cost upwards of 900 million dollars and around 12 years of development to reach a market. CRO’s have been…
Harnessing the power of emerging markets
Biosimilar development costs are high with some industry leaders claiming estimates of $100-150 million. Even after this substantial investment there is no guarantee of immediate…
UK Business Secretary Vince Cable endorses SMi conference key speaker
Vince Cable yesterday endorsed progress in large-scale electricity storage by Isentropic, a key speaker at SMi's upcoming Grid-Scale Energy Storage conference. Using a combined heat…
Are exacerbations the most relevant outcome parameters in COPD clinical trials?
COPD is a life threatening disease which negatively affects normal breathing. It is characterised by persistent blockage of air flow to the lungs. COPD encapsulates…
Next-generation Demand Response software IDROP due to arrive in Europe
‘The electric power industry is going to require powerful analytical engines as we enter the era of Demand Response 2.0...but many of us seem to…
Discuss novel strategies to improve success in cancer vaccines clinical trials i …
There is a great deal of unmet need in the effective treatment of numerous types of cancer, as long-term survival rates are still rather poor…
Discuss challenges facing new biobanks and building sustainability in London
Single centre research facilities are evolving into research infrastructures as both the number of national biobanks and the efforts to build co-operative networks between them…
Meet & network with industry experts at Air Mission Planning 2012
With less than 2 weeks until Air Mission Planning 2012, don’t miss this must-attend event for the mission planning community, providing the perfect forum for…
Focus on the latest developments in air mission planning
SMi’s 3rd annual Air Mission Planning conference returns to London in less than one month’s time to bring together the foremost experts from: Joint Helicopter…
SMi’s inaugural ADC Summit, 23rd & 24th May 2012, London
Antibody Drug Conjugates are used to fight cancerous cells and are made up of the antibody that will target a specific tumour0-associated antigen a drug…
Understanding how social media benefits the patient and healthcare professionals
The pharmaceutical industry has been waiting for guidance from the FDA and now they have finally shed some light with their 'Off-Label Use' with some…
A Global outlook for the Generics Industry: from commodity to value added Generi …
With only a month to go, SMi is pleased to invite you to attend its Generics, Supergenerics and Patent Strategies conference that will provide you…
Meet industry experts & discuss the latest advances in drug development at SMi†…
Join SMi at the 12th annual Pain Therapeutics conference, which will be held on 21st & 22nd May 2012 in London, UK.
Pain is the most…
How can smaller companies survive in the European generics industry
SMi's is pleased to announce its Generics, Supergenerics and Patent Strategies conference that will provide you with an excellent overview of the industry and where…
Strategies for Pharmaceutical Portfolio & Product Life-Cycle Management in face …
There is less than a month away for SMi’s 7th annual Pharmaceutical Portfolio & Lifecycle Management held on the 18th & 19th April in London.…
Challenges facing new biobanks, strategies for cost recovery and sustainability
Access to samples is paramount to scientific research. Biological samples such as DNA, RNA, proteins, cells and tissues are collected from donors, processed and stored…
Examine the latest developments & current issues at SMi’s inaugural ISR confer …
Don't miss SMi's inaugural ISR conference, which will be held in London on 18th & 19th April 2012.
This must-attend event will bring delegates and key…
Discuss crucial topics & global issues at SMi’s 6th annual MilSpace conference …
SMi's MilSpace 2012 conference is fast approaching, so don’t miss out on this unique opportunity to register for this outstanding event. After 5 successful events,…
Consider novel linker strategy techniques to increase efficacy of ADC products
Antibody Drug Conjugates are used to fight cancerous cells and are made up of the antibody that will target a specific tumour0-associated antigen a drug…
Extend product lifecycles through reformulation to keep market share
Join SMi at their 9th annual Controlled Release conference to be held on the 28th & 29th March 2012 London. This must-attend event will once…
Why are the boundaries between innovator and generic companies are becoming blur …
The pharmaceutical generics industry is a fast moving and is a consistently expanding one. With the much referenced patent cliff rapidly approaching, all businesses are…
6th annual Clinical Trial Logistics Conference
SMi present their 6th annual Clinical Trial Logistics event to be held in London on Tuesday 22nd & Wednesday 23rd of May 2012. This event…
Network with key industry players at Mobile Deployable Communications 2012, taki …
SMi's Mobile Deployable Communications conference is fast approaching, so don't miss this opportunity to register for this outstanding event. Building on the success of the…
Extend product lifecycles through reformulation to keep market share
Join SMi at their 9th annual Controlled Release conference to be held on the 28th & 29th March 2012 London. This must-attend event will once…
The latest developments of specific-spectrum, anti-staphyloccal agents using in- …
Now in its 14th year, Superbugs & Superdrugs is a well established antibacterial event that promises to be the perfect forum for networking and problem…
Translational Imaging to improve probability of success in drug development
Join SMi at their 8th annual Imaging in Cancer Drug Development conference that promises to be interactive and informative. With an increasing verity of imaging…
Smart water meter market poised for growth | Smart Water Systems, 16-17 April 20 …
“The smart water meter market is poised for steady growth in the coming 5 years, driven by increasing demand for water itself, aging system infrastructure,…
Only 3 weeks left to the leading forum for border security professionals in the …
SMi's inaugural Border Security Asia Pacific conference and exhibition is the only event within the Asia Pacific region to bring together key speakers and professionals…
Network with leading experts at the JFS&T conference, taking place in 2 weeks
SMi’s 3rd annual Joint Forces Simulation & Training conference, to be held in London on 24th and 25th January 2012, is designed to address the…
SMi’s Pharmaceutical Portfolio & Product Lifecycle Management held on 18th & 1 …
Assessing Portfolio value and risk
With declining R&D costs, prioritizing a portfolio of successful projects has become essential within the pharmaceutical industry. Lifecycle management approaches must…
SMi’s Pharmaceutical Portfolio & Product Lifecycle Management held on 18th & 1 …
With declining R&D costs, prioritizing a portfolio of successful projects has become essential within the pharmaceutical industry. Lifecycle management approaches must be implemented throughout a…
SMi’s 9th annual Controlled Release conference held on the 28th & 29th March 2 …
As formulation and delivery for small molecule and biologics becomes ever more important, targeted delivery and lifecycle extension remain an ongoing need for all concerned.…
SMi's Paediatric Clinical Trials conference held on the 21st & 22nd March 2012, …
Many drugs which are prescribed to children have not been adequately studied in the paediatric population. Pharmaceutical companies are now required to produce medicines specifically…
SMi's Orphan Drugs conference held on December 7, 2011
SMi’s Orphan Drugs masterclass aims to tackle the development of orphan drug treatments and the unique challenges involved.
The masterclass will help delegates understand what…
SMi’s 9th annual Controlled Release conference held on the 28th & 29th March 2 …
Challenges and solutions in the delivery of a prodrug in an oral, extended-release delivery system
As formulation and delivery for small molecule and biologics becomes ever…
SMi’s 8th annual Imaging in Cancer Drug Development held on 14th &15th March 2 …
Effective treatments for a wide verity of cancers are still very slow and costly to develop with many prospective drugs ending up in being scraped.
With…
